![Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial - The Lancet Neurology Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8c117d0f-9be9-46eb-90df-f51cbd9ae1c1/gr1.gif)
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial - The Lancet Neurology
![SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) | SpringerLink SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12094-022-02788-w/MediaObjects/12094_2022_2788_Fig2_HTML.png)
SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) | SpringerLink
![ESMO21 Highlights on nivolumab in pretreated thymoma & thymic carcinoma: EORTC-ETOP NIVOTHYM study - YouTube ESMO21 Highlights on nivolumab in pretreated thymoma & thymic carcinoma: EORTC-ETOP NIVOTHYM study - YouTube](https://i.ytimg.com/vi/WoHx9-654Rs/maxresdefault.jpg)
ESMO21 Highlights on nivolumab in pretreated thymoma & thymic carcinoma: EORTC-ETOP NIVOTHYM study - YouTube
![Thymoma and Thymic Carcinoma Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Thymoma and Thymic Carcinoma Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK65958/bin/CDR0000774646.jpg)
Thymoma and Thymic Carcinoma Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
![Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis - Álvarez‐Velasco - 2021 - European Journal of Neurology - Wiley Online Library Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis - Álvarez‐Velasco - 2021 - European Journal of Neurology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/da22cea1-2ce9-4c02-a6b3-3789f9e34309/ene14820-fig-0002-m.jpg)
Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis - Álvarez‐Velasco - 2021 - European Journal of Neurology - Wiley Online Library
![Frontiers | Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm | Oncology Frontiers | Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm | Oncology](https://www.frontiersin.org/files/Articles/583781/fonc-10-583781-HTML-r1/image_m/fonc-10-583781-g001.jpg)
Frontiers | Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm | Oncology
![Clinical trial studies immunotherapy combination for recurrent thymoma and thymic carcinoma | Center for Cancer Research Clinical trial studies immunotherapy combination for recurrent thymoma and thymic carcinoma | Center for Cancer Research](https://ccr.cancer.gov/sites/default/files/styles/quarter_1_1/public/rajan_updated_400x400_0.png?itok=w3h_Bk5R)
Clinical trial studies immunotherapy combination for recurrent thymoma and thymic carcinoma | Center for Cancer Research
![Phosplatin Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of PT-112 for Thymoma and Thymic Carcinoma in Collaboration with National Cancer Institute Phosplatin Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of PT-112 for Thymoma and Thymic Carcinoma in Collaboration with National Cancer Institute](https://mma.prnewswire.com/media/552886/Phosplatin_Therapeutics_LLC_Logo.jpg)
Phosplatin Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of PT-112 for Thymoma and Thymic Carcinoma in Collaboration with National Cancer Institute
Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses
![SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) | SpringerLink SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12094-022-02788-w/MediaObjects/12094_2022_2788_Fig1_HTML.png)
SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) | SpringerLink
![Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: A phase II, multi-institutional clinical trial - ScienceDirect Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: A phase II, multi-institutional clinical trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S002252231301043X-gr1.jpg)